TCR2 THERAPEUTICS, INC. CONSULTING AGREEMENTConsulting Agreement • December 28th, 2018 • Tcr2 Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledDecember 28th, 2018 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is effective October 1st, 2017 (the “Effective Date”) and entered into by TCR2 Therapeutics, Inc., a Delaware corporation (the “Company”), and Globeways Holdings Limited, a British Virgin Islands corporation with a correspondence address at 8 Rue Saint Leger, 1205 Geneva, Switzerland (the “Consultant”).
TCR2 THERAPEUTICS, INC. CONSULTING AGREEMENTConsulting Agreement • September 7th, 2018 • Tcr2 Therapeutics Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledSeptember 7th, 2018 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) is effective October 1st, 2017 (the “Effective Date”) and entered into by TCR2 Therapeutics, Inc., a Delaware corporation (the “Company”), and Globeways Holdings Limited, a British Virgin Islands corporation with a correspondence address at 8 Rue Saint Leger, 1205 Geneva, Switzerland (the “Consultant”).